NEW YORK (MainStreet) — Post Traumatic Stress Disorder ( PTSD) is one of the many conditions that medical marijuana can help treat. The main problem to date faced by those who suffer from the condition has been the lack of funds to study the condition in a controlled scientific environment.
While the National Institutes of Health (NIH) has funded medical trials to study the medical effects of marijuana across a range of conditions, up until now this money has predominately funded research in other countries, from Israel to Canada. Furthermore, the National Institute for Drug Abuse (NIDA) overwhelmingly gave approval for researchers to use its cannabis stock, grown in Mississippi, for understanding the interplay between cannabis and addiction rather than to treat medical conditions.
That is beginning to change. The state of Colorado is now funding medical research with some of the proceeds from its year-and-a-half-old recreational market. Perhaps the best known recipient of such research money is the infamous trial headed by Dr. Sue Sisley and her team of experts to study the effect of pot on PTSD. After being given approval to move forward by the Department of Health and Human Services, the FDA and the DEA, Sisley was fired from the University of Arizona last year over her efforts. She subsequently received a $2 million grant from Colorado state's Medical Marijuana Scientific Advisory Council, set up an independent lab to perform the study and obtained the approval of NIDA to use its marijuana stocks for her research. Even more importantly, Sisley and her team have selected 76 veterans to take part in the study.